MU8-80232-74893
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 325 / FL
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 1 — Pfizer-BioNTech
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-12
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-15
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitAdult check-in
-
2021-02-15
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-20
Health check-in — day 7, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-24
-
2021-03-03
Dose 2 — Pfizer-BioNTech
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to workAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-19
- 2021-03-24
- 2021-04-02
- 2021-04-07
- 2021-04-14
- 2021-06-02
- 2021-08-01
-
2021-08-22
Dose 3 — Pfizer-BioNTech
-
2021-09-01
Survey response — 6 months, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-01
Survey response — day 35, dose 3MedDRA: Arthralgia, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache. Joint painMedDRA releases: 2024-11 · check-in free text available
- 2021-10-05
- 2021-11-23
- 2022-02-20
-
2022-08-22
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-08-22
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-23
- 2022-08-23
-
2022-08-29
Call successfulParticipant prefers to complete VAERS report online
-
2022-08-29
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2021-08-22 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
1 wait over 3 months for a first call
Free text
Release 9 — 6 months, dose 2
Symptoms: Headaches
Release 9 — day 35, dose 3
Symptoms: Headache. Joint pain
Release 12 — 12 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release